Abstract 57: Ibrutinib improves chimeric antigen receptor T cell control of leukemia by inhibiting myeloid-derived suppressor cells
Year: 2024
Type: conference-abstract
Source: Cancer Research
Institutions: University of Pennsylvania, University of Cincinnati
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4393097133